John Cuozzo is currently senior vice president in Drug Discovery at ZebiAI Therapeutics. ZebiAI Therapeutics is focused on applying machine learning (ML) at all stages of small molecule drug discovery to accelerate target validation and advance new therapeutics for unmet medical needs. ML algorithms are combined with large datasets from small molecule screens to access vast chemical space for drug discovery in a time and cost effective manner.